Atlas Trials

Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection

Clinical trial NCT04438694 · UNKNOWN

Trial details

NCT number
NCT04438694
Sponsor
Cairo University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID19
Start date
2020-06-01
Primary completion
2021-05-31
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.